newsfilter
← Latest News
Business Wire·

Evolus to Participate in Upcoming Investor Conferences in New York and London

  • Evolus, Inc. (NASDAQ: EOLS) announced that its management team will attend two investor conferences in New York and London.
  • The Stifel Healthcare Conference will feature a fireside chat at 2:00 PM ET on Wednesday, November 11, 2026, in New York City, with a live webcast available on the company's Investor Relations page.
  • The Jefferies Global Healthcare Conference will host investor meetings in London, United Kingdom, on November 16–17, 2026.
  • The webcast replay for the Stifel fireside chat will remain accessible for 90 days following the presentation.
  • Evolus operates as a global performance beauty company with an aesthetic portfolio including Jeuveau, Evolysse, 1 Profhilo, 1 Nuceiva, 1 \& Nuceiva.
  • Jeuveau is the first neurotoxin dedicated exclusively to aesthetics, while Profhilo is licensed for development in the U.S. as a market-leading injectable for skin quality in Europe.